Share Price

follow quotes on

Major Shareholders

1
2
3
4
5
6
1

François Fornieri 1

32.61%

2

Free Float

26.77%

3

Marc Coucke 2

16.49%

4

Meusinvest SA

16.09%

5

OGEO Fund OFP

4.76%

6

Bart Versluys 3

3.28%

1 François Fornieri formerly also held his shareholding partially through Mithra Participations (a société civile de droit commun) of which he is the director, but which was resolved on 21 December 2016. As disclosed previously, François Fornieri also holds warrants entitling him to subscribe 1,211,100 additional shares of Mithra.

2 Marc Coucke holds his shareholding partially through Alychlo NV and Mylecke Management Art & Invest NV, which he both controls.

3 Bart Versluys holds his shareholding through Scorpiaux BVBA and Versluys Bouwgroep BVBA, which he both controls.

Voting Rights

Total number of voting rights (denominator)

34,242,731

(all relating to ordinary shares)

Total number of securities carrying voting rights

34,242,731

(all ordinary shares)

Total number of securities carrying voting rights not yet issued

1,796,850

(all related to warrants issued on 2 March 2015 and potentially to be exercised as from 2019)

Transparency Declarations

The Articles of the Association of Mithra Pharmaceuticals SA provide for an additional notification threshold of 3% of the total number of existing voting rights.

Bart Versluys

22 January 2016

François Fornieri

11 July 2015

Meusinvest SA

11 July 2015

Marc Coucke Alychlo NV

11 July 2015

OGEO

11 July 2015

Completed and signed forms should be sent to investorrelations@mithra.com

Analyst Coverage

ING

KBC SECURITIES

Financial Service

The financial service related to transactions involving the Shares of the Company is ensured in Belgium by ING. Should the Company alter its policy in this matter, any change will be announced in the Belgian financial press and on the Company’s website.

© Copyright 2015 Mithra Pharmaceuticals